Information  X 
Enter a valid email address

Broker Forecast - Societe Generale issues a broker note on GlaxoSmithKline PLC

By BFN News | 01:40 PM | Thursday 09 January, 2020

Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2300p (from 2200p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t